Increased expression of α-synuclein by SNCA duplication is associated with resistance to toxic stimuli
- PMID: 22392151
- DOI: 10.1007/s12031-012-9732-6
Increased expression of α-synuclein by SNCA duplication is associated with resistance to toxic stimuli
Abstract
Duplication of alpha-synuclein gene (SNCA) is a recognized cause of Parkinson's disease (PD). However, the penetrance in families with SNCA duplication is as low as 30%, indicating that factors other than the SNCA gene dosage have an important role in neuronal death. In this study, using lymphoblastoid cell lines (LCLs) derived from a parkinsonian kindred with SNCA duplication, we examined whether there is difference in (1) the level of SNCA mRNA and protein expression and cell viability and (2) the vulnerability to various insults relevant to PD between a patient, asymptomatic carrier, and unaffected control. Expression of SNCA mRNA and protein increased in the LCLs from subjects with SNCA gene duplication, irrespective of the disease status. In the absence of treatment, LCLs from the patient and carrier showed decreased viability compared with the LCL from the control. The LCL from the patient also showed decreased viability compared to the carrier. When susceptibility to various insults including lactacystin, dexamethasone, 3-methyladenine, H(2)O(2), and rotenone was examined, surprisingly, the LCL from the patient was more resistant than the LCL from the control to all agents except for lactacystin. This study shows that both intrinsic and extrinsic factors and their interaction have important roles in cell death and in the development of PD and further indicates that the relationship between cell death and the level of alpha-synuclein may be more complicated than previously thought.
Similar articles
-
Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.Ann Neurol. 2006 Feb;59(2):298-309. doi: 10.1002/ana.20753. Ann Neurol. 2006. PMID: 16358335
-
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.Mol Neurodegener. 2015 Aug 27;10:41. doi: 10.1186/s13024-015-0038-3. Mol Neurodegener. 2015. PMID: 26306801 Free PMC article.
-
A 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.JAMA Neurol. 2014 Sep;71(9):1162-71. doi: 10.1001/jamaneurol.2014.994. JAMA Neurol. 2014. PMID: 25003242 Free PMC article.
-
[Relationship between alpha-synuclein and Parkinson's disease].Brain Nerve. 2007 Aug;59(8):825-30. Brain Nerve. 2007. PMID: 17713118 Review. Japanese.
-
Autosomal dominant Parkinson's disease caused by SNCA duplications.Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1(Suppl 1):S1-6. doi: 10.1016/j.parkreldis.2015.09.007. Epub 2015 Sep 3. Parkinsonism Relat Disord. 2016. PMID: 26350119 Free PMC article. Review.
Cited by
-
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.Nature. 2016 May 5;533(7601):95-9. doi: 10.1038/nature17939. Epub 2016 Apr 20. Nature. 2016. PMID: 27096366 Free PMC article.
-
Using induced pluripotent stem cells for modeling Parkinson's disease.World J Stem Cells. 2019 Sep 26;11(9):634-649. doi: 10.4252/wjsc.v11.i9.634. World J Stem Cells. 2019. PMID: 31616540 Free PMC article. Review.
-
The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein.Neural Regen Res. 2015 Jul;10(7):1113-9. doi: 10.4103/1673-5374.160106. Neural Regen Res. 2015. PMID: 26330835 Free PMC article.
-
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.Metabolites. 2023 Dec 31;14(1):30. doi: 10.3390/metabo14010030. Metabolites. 2023. PMID: 38248833 Free PMC article.
-
Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease.Brain Behav. 2021 Aug;11(8):e2280. doi: 10.1002/brb3.2280. Epub 2021 Jul 21. Brain Behav. 2021. PMID: 34291612 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous